Target intelligence / Profile preview

Lysine-rich coiled-coil protein 1 (KRCC1)

Target
KRCC1
Molecular classification
Other (nuclear chromatin-associated protein, modulator of protein complexes HDAC and PP1)
01

Overview

Lysine-rich coiled-coil protein 1 (KRCC1) is a nuclear protein, enriched at chromatin and characterized by a lysine-rich coiled-coil C-terminal region[1][2]. It consists of 259 amino acids and contains computationally predicted nuclear localization signals (NLS), contributing to its predominant nuclear localization[1]. KRCC1 is frequently overexpressed in high-grade serous ovarian cancer and its elevated expression correlates with poor overall survival and chemoresistance[1][2]. The protein interacts with histone deacetylases (HDAC1, HDAC2) and the serine/threonine phosphatase PP1CC, modulating chromatin structure and DNA repair processes[1][2]. Functionally, KRCC1 is involved in the DNA damage response, especially via regulation of CHK1-mediated checkpoint activation, homologous recombination, and cell cycle progression. Knockdown or inhibition of KRCC1 induces apoptosis, impairs cancer cell invasion, increases histone acetylation, and leads to enhanced DNA damage signaling[1][2]. These findings support KRCC1 as a promising therapeutic target in ovarian cancer and possibly other malignancies due to its role in cell survival and genomic stability[1][2].

Other names
Lysine rich coiled-coil 1KRCC1CHBP2BM-003BM-044FLJ22333Cryptogenic hepatitis-binding protein 2cryptogenic hepatitis-binding protein 2
02

Biological functions

DNA damage responseRegulation of cell cycle progressionHomologous recombination repairRegulation of cellular plasticityApoptosis modulation
03

Disease associations

Cancer (notably ovarian cancer)Potential role in other malignancies (pan-cancer implications suggested)

Beyond the preview

Go deeper on Lysine-rich coiled-coil protein 1 (KRCC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysine-rich coiled-coil protein 1 (KRCC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call